Thomas N. Tozer

University Hospital of Wales — United Kingdom

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

32h-index4.0kcitations84works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacogenetics and Drug Metabolism(13), Analytical Methods in Pharmaceuticals(11), Pharmaceutical studies and practices(10), Drug Transport and Resistance Mechanisms(8), Analytical Chemistry and Chromatography(8)

Publications84 total

Whole blood‐based measurement of SARS‐CoV‐2‐specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid‐organ cancers
Immunology·2021· 25 citedOpen Access
Whole blood-based measurement of SARS-CoV-2-specific T cell responses reveals asymptomatic infection and vaccine efficacy in healthy subjects and patients with solid organ cancers
2021· 2 citedOpen Access
What Computers Will Never Be Able To Do
2020
Chapter 5 Pharmacokinetic Principles Relevant to Bioavailability Studies
2015
farmakokinetika & Farmakodinamika: Dasar Kuantitatif terapi Obat
2011
Clinical pharmacokinetics and phamacodynamics: concepts and applications
2011
Clinical pharmacokinetics and pharmacodynamics : concepts and applications
2011· 367 cited
Introduction to Pharmacokinetics and Pharmacodynamics: The Quantitative Basis of Drug Therapy
2006· 107 cited
Considerations in the Attainment of Steady State: Aggregate vs. Individual Assessment
Pharmaceutical Research·1998· 7 cited
Modeling the Acute Neurotoxicity of Styrene
Journal of Occupational and Environmental Medicine·1998· 10 cited
Evaluation of Bioequivalence of Highly Variable Drugs Using Clinical Trial Simulations. II: Comparison of Single and Multiple-Dose Trials Using AUC and Cmax
Pharmaceutical Research·1998· 32 cited
Cmax/AUC, a commentary.
Pharmaceutical Research·1997· 11 cited
Absorption Rate Vs. Exposure: Which Is More Useful for Bioequivalence Testing?
Pharmaceutical Research·1996· 60 cited
Glucocorticoid–Dextran Conjugates as Potential Prodrugs for Colon-Specific Delivery: Hydrolysis in Rat Gastrointestinal Tract Contents
Journal of Pharmaceutical Sciences·1994· 98 cited
Bioequivalence: Performance of Several Measures of Rate of Absorption
Pharmaceutical Research·1994· 96 cited
Bioequivalence: Performance of Several Measures of Extent of Absorption
Pharmaceutical Research·1994· 61 cited
Glucocorticoid‐dextran conjugates as potential prodrugs for colonspecific delivery: Steady‐state pharmacokinetics in the rat
Biopharmaceutics & Drug Disposition·1994· 41 cited
A glucocorticoid prodrug facilitates normal mucosal function in rat colitis without adrenal suppression
Gastroenterology·1994· 43 citedOpen Access
Pentachlorophenol Carcinogenicity: Extrapolation of Risk from Mice to Humans
Human & Experimental Toxicology·1993· 21 cited
Pharmacokinetic Concepts in Assessing Intake of Pentachlorophenol by Rats after Exposure through Drinking Water
Journal of Pharmaceutical Sciences·1992· 4 cited
page 1 of 5Next →

Frequent Co-authors

Frédéric Y. Bois(6), David R. Friend(5), Bruno Reigner(5), Andrew McLeod(4), Roger Williams(4), William Couet(4), L. Dallas Tuck(4), Susan M. Pond(3), Norton H. Neff(3), Bernard B. Brodie(3), Sidney Riegelman(3), Walter W. Hauck(3), Mei‐Ling Chen(3), Ulf G. Eriksson(3), Robert C. Brasch(3), Jean F. Rigod(3), Gerald M. Rubin(3), Malcolm Rowland(2), Svein Øie(2), Ernst Martin(2)